DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Dept. of Defense — CDMRP · Other Federal · HT942526TBIPHRPCTA
Source: Grants.gov · View original posting ↗
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- $18.6M total
- DeadlineFinal application due date.
- Oct 15, 2026
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- 6
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Unknown
- Open dateWhen applications open (or opened).
- May 21, 2026
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $18.6M total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Unspecified
Research areas
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Summary: The fiscal year 2026 (FY26) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Clinical Trial Award (CTA) intends to support clinical trials with the potential to have a significant impact on psychological health conditions and/or traumatic brain injury (TBI) through clinical applications, including health care products, technologies and/or practice guidelines. Distinctive Features: Funding from this award mechanism must support a clinical trial. · Clinical trials may be designed to evaluate a wide range of interventions, including new drugs, biologics, medical devices, diagnostics, therapies and behavioral health strategies. · Preliminary data are required. · The inclusion of community-based participatory research (CBPR) approaches is required. · The CTA offers funding for two Research Levels. The applicant is responsible for selecting the Research Level based on the scope of the research. ○ Research Level 1: Supports proof-of-principle pilot studies, as well as phase 1 and phase 2 clinical trials. ○ Research Level 2: Supports larger-scale and advanced clinical trials that evaluate effectiveness in relevant patient populations. · Early-Career Investigator Partnering Option ( available for both Research Levels ): This option accommodates two Principal Investigators (PIs), one of which is an Early-Career Investigator. If recommended for funding, each PI will receive a separate award.